Account
Leo Burnett India wins Sterlite Technologies account
MUMBAI: Leo Burnett India has bagged the account of Sterlite Technologies, which is a provider of solutions for high speed data and power transmission networks. The agency won the account after a multi agency pitch.
This marks as a step to redefine the company’s brand purpose keeping in mind the changing market landscape and opportunities in its field of operation.
Sterlite Technologies CEO Dr Anand Agarwal said, “In line with our current organisational demerger, we wish to redefine our core purpose and communicate clearly what we do, and how we make a difference in the life of every one who is connected to us. It is with this belief we have appointed Leo Burnett, which has a rich history of defining the purpose for many great brands and helping them grow in complex business scenarios. They will help us re-define and disseminate our purpose amongst our employees and other stakeholders, thus laying a robust foundation for future growth.”
Sterlite Technologies recently completed the acquisition of Elitecore Technologies, a global telecom software product company in a bid to widen its telecom portfolio of offering to global customers.
Leo Burnett India CEO Saurabh Verma added, “We are witnessing a tremendous change on a global and socioeconomic landscape, thanks to the evolution of Internet and a greater degree of connectivity. The services provided by Sterlite are at the very core of this spurt, impacting positively at micro and macro levels. It is very exciting to partner a company that is playing a key role in the changing dynamics of technology in our lives. We will deploy our HumanKind tools to re-define Sterlite’s human purpose and help create a sustainable brand identity amongst the company’s stakeholders. We hope our rich experience in this field will eventually prove to be of great value to the organisation.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
